Your browser doesn't support javascript.
loading
Cost-Effectiveness of Anti-Epidermal Growth Factor Receptor Therapy Versus Bevacizumab in KRAS Wild-Type (WT), Pan-RAS WT, and Pan-RAS WT Left-Sided Metastatic Colorectal Cancer.
Lee, Shing Fung; Choi, Horace C W; Chan, Sik Kwan; Lam, Ka On; Lee, Victor H F; Wong, Irene O L; Chiang, Chi Leung.
Afiliação
  • Lee SF; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hong Kong, Hong Kong.
  • Choi HCW; Department of Clinical Oncology, University of Hong Kong, Hong Kong, Hong Kong.
  • Chan SK; Department of Clinical Oncology, University of Hong Kong, Hong Kong, Hong Kong.
  • Lam KO; Department of Clinical Oncology, University of Hong Kong, Hong Kong, Hong Kong.
  • Lee VHF; Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Wong IOL; Department of Clinical Oncology, University of Hong Kong, Hong Kong, Hong Kong.
  • Chiang CL; Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Front Oncol ; 11: 651299, 2021.
Article em En | MEDLINE | ID: mdl-34012917
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article